![]() |
市场调查报告书
商品编码
1721455
微型电脑断层扫描市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测Micro Computed Tomography Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球微型电脑断层扫描市场价值为 2.769 亿美元,预计到 2034 年将以 8.2% 的复合年增长率成长,达到 6.048 亿美元。微型电脑断层扫描 (micro-CT) 是一种强大的成像技术,可提供内部结构的超高解析度 3D 影像,实现无与伦比的精确度和细节。工业和科学应用对先进成像解决方案的需求不断增长,推动了该市场的大幅成长。
Micro-CT 系统提供无损检测功能,这在需要高水准品质保证的行业(例如航太、汽车和电子)中尤其有价值。随着技术的不断进步,包括更快的扫描时间、更高的解析度和更紧凑的系统,微型 CT 正在发展成为一种用途广泛的工具。它不仅支持关键的研发活动,而且在新材料和新产品的商业化中发挥关键作用。人工智慧和机器学习在自动影像分析中的整合进一步提高了微型 CT 系统的效率和准确性,使其在各个领域变得更加不可或缺。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 2.769亿美元 |
预测值 | 6.048亿美元 |
复合年增长率 | 8.2% |
微型 CT 最初是为生物医学和医疗保健成像而开发的,多年来其应用范围已显着扩大。能够在不损坏物体的情况下以 3D 形式可视化微观结构,这使其非常适合用于材料科学、生物学、电子学和地质学研究。製造环境中对精密工程和品质控制的日益重视,扩大了全球对微型 CT 系统的需求。此外,製药和生物技术研究的激增,特别是临床前研究和药物开发,推动了生命科学的广泛应用。
市场依产品类型分为体内微型 CT 和体外微型 CT。 2024 年,体外微型 CT 领域将占据 77.2% 的主导份额。体外系统因其能够极其清晰地扫描提取的样本而被广泛应用于材料科学、生物学和医疗保健成像。这些系统对于需要对生物样本或结构材料进行详细内部成像而不改变或破坏它们的研究人员特别有益。它们提供的超高解析度成像对于探索各种应用中的微观细节至关重要。
Micro-CT 有多种关键应用,包括生命科学、牙科、骨骼研究、植物和食品分析、材料科学以及地质学或石油和天然气。 2024 年,生命科学领域以 38.2% 的市占率领先市场。微型 CT 能够提供组织和器官的详细、非侵入性 3D 视觉化,这使其在肿瘤学、心臟病学和神经病学等领域至关重要。它支持从假设检验到药物开发和疾病建模验证的整个研究生命週期。
2023 年,美国微型电脑断层扫描市场规模达 9,750 万美元,预计到 2034 年将达到 2.277 亿美元。强劲的研发投入、先进诊断工具的采用以及不断增长的工业应用将继续推动该国市场扩张。
影响竞争格局的主要参与者包括布鲁克、珀金埃尔默、蔡司、TESCAN、岛津、Micro Photonics、理学、北极星成像、台达电子、NeoScan、SCANCO Medical 和三英精密仪器。这些公司正在大力投资研发并扩大其产品组合,包括具有更高解析度、更快扫描速度和用户友好功能的系统。与学术机构和行业利益相关者的策略合作伙伴关係也在扩大其全球影响力和增强创新方面发挥核心作用。
The Global Micro Computed Tomography Market was valued at USD 276.9 million in 2024 and is estimated to grow at a CAGR of 8.2% to reach USD 604.8 million by 2034. Micro computed tomography (micro-CT) is a powerful imaging technology that delivers ultra-high-resolution 3D images of internal structures, enabling unmatched accuracy and detail. The increasing demand for advanced imaging solutions across both industrial and scientific applications is driving substantial growth in this market.
Micro-CT systems offer non-destructive testing capabilities that are especially valuable in industries requiring high levels of quality assurance, such as aerospace, automotive, and electronics. With ongoing technological advancements, including faster scan times, improved resolution, and more compact systems, micro-CT is evolving into a highly versatile tool. It not only supports critical R&D activities but also plays a pivotal role in the commercialization of new materials and products. The integration of AI and machine learning for automated image analysis is further enhancing the efficiency and accuracy of micro-CT systems, making them even more indispensable across diverse sectors.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $276.9 Million |
Forecast Value | $604.8 Million |
CAGR | 8.2% |
Initially developed for biomedical and healthcare imaging, micro-CT has significantly broadened its reach over the years. The ability to visualize microstructures in 3D without damaging the object makes it ideal for use in material science, biology, electronics, and geological research. The growing emphasis on precision engineering and quality control across manufacturing environments is amplifying the demand for micro-CT systems worldwide. Moreover, the surge in pharmaceutical and biotech research, especially in preclinical studies and drug development, has fueled widespread adoption in life sciences.
The market is segmented by product type into in vivo and ex vivo micro-CT. In 2024, the ex vivo micro-CT segment accounted for a dominant 77.2% share. Ex vivo systems are widely used in material science, biology, and healthcare imaging for their ability to scan extracted samples with extreme clarity. These systems are particularly beneficial for researchers who need detailed internal imaging of biological specimens or structural materials without altering or destroying them. The ultra-high-resolution imaging they offer is critical in exploring microscopic details in various applications.
Micro-CT serves several key applications, including life science, dentistry, bone research, plant and food analysis, material science, and geology or oil and gas. In 2024, the life science segment led the market with a 38.2% share. The ability of micro-CT to offer detailed, non-invasive 3D visualization of tissues and organs makes it crucial in fields like oncology, cardiology, and neurology. It supports the entire research lifecycle from hypothesis testing to validation in drug development and disease modeling.
The U.S. Micro Computed Tomography Market generated USD 97.5 million in 2023 and is anticipated to reach USD 227.7 million by 2034. Robust R&D investments, adoption of advanced diagnostic tools, and growing industrial applications continue to drive market expansion in the country.
Key players shaping the competitive landscape include Bruker, PerkinElmer, Zeiss, TESCAN, Shimadzu, Micro Photonics, Rigaku, North Star Imaging, Delta Electronics, NeoScan, SCANCO Medical, and Sanying Precision Instruments. These companies are investing heavily in R&D and expanding their product portfolios to include systems with superior resolution, faster scanning speeds, and user-friendly features. Strategic partnerships with academic institutions and industry stakeholders are also playing a central role in extending their global footprint and enhancing innovation.